ReviewArchives of microbiology2026
Fusaricidins producing Paenibacillus: a potential biocontrol agent against plant pathogens.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phytopathogens are responsible for substantial yield losses in global agriculture. Significant use of chemical fungicides for controlling these pathogens often poses a threat to the environment. Thus, the application of fusaricidin-producing Paenibacillus offers a promising and eco-friendly alternative to conventional chemical control strategies. Fusaricidins possess a hexapeptide core linked to a consistent 15-guanidino-3-hydroxypentadecanoic acid tail, which is instrumental in membrane disruption and the eradication of a broad spectrum of pathogens. Recent genomic mining studies have identified the fusGFEDCBA gene cluster and elucidated the pivotal role of the KinB-Spo0A-AbrB signaling cascade in integrating environmental stimuli with the developmental regulation of fusaricidin biosynthesis. Beyond their direct antimicrobial effects, fusaricidins function as plant-defense elicitors, primarily activating systemic responses through salicylic acid (SA)-dependent pathways. In vitro, greenhouse, and field trials have demonstrated significant disease suppression and plant growth promotion across various crops. However, variability in field performance, challenges in formulation, and limited understanding of in-field stability and ecological interactions present significant barriers to commercialization. Through integrated molecular and applied research, these limitations and future directions are being addressed. Collectively, these insights position fusaricidins as promising candidates for sustainable plant disease management in agriculture. This review concentrates on the current understanding of fusaricidins, encompassing their chemical diversity, biosynthetic gene architecture, regulatory networks, mechanisms of antimicrobial action, and advancements toward field-level application.
Indexed as
Identifiers
42101669What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.